Trial intelligence / Profile preview

Remimazolam vs midazolam for sedation in mechanically ventilated sepsis patients in ICU

ChiCTR2300076671Phase 4Recruiting

Sponsor
First Affiliated Hospital of Kunming Medical University
Start
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in sepsis (2 arms), sponsored by First Affiliated Hospital of Kunming Medical University. Primary endpoint: RASS Score. Started Oct 2023; status: recruiting.

02

Drugs

remimazolam
03

Conditions

sepsis

Beyond the preview

Go deeper on ChiCTR2300076671.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300076671.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call